The effect of the EMD protocol for urge compared to care as usual on dermatology-specific quality of life
- Conditions
- Prurigo nodularis (nodular prurigo)Atopic dermatitis (eczema)10014982
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
- Age 18 >=
- A confirmed diagnosis of atopic dermatitis or prurigo nodularis
- Suffering from persistent and frequent scratching behaviour
- IGA-CPG activity score >= 3 OR Skindex-29 symptoms subscale score >= 42
- Stable course of treatment in the two weeks prior to the study (no medication
change, etc.)
- Sufficiently motivated to take part in a new intervention aimed at behaviour
change
Exclusion Criteria
- Insufficient understanding of Dutch language
- Severe psychiatric disorders that require treatment first, such as delusional
disorder or major depression
- If medication is changed during the course of the study, the participant will
be considered a drop-out from the moment the medication has changed.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study outcome is the dermatology-specific health-related quality of<br /><br>life (HRQOL), measured at the start of the study (T0), in week 4 (T1), in week<br /><br>8 (T2), and during follow-up, in week 12 (T3) and six months after T0 (T4). The<br /><br>SKINDEX-29 is used to measure this outcome. It consists of 30 items to be<br /><br>scored on a 5-point response scale. The instrument has three subscales:<br /><br>symptoms, emotions, and functioning [17].<br /><br><br /><br><br /><br>17. Chren, M.-M., et al., Improved discriminative and evaluative capability of<br /><br>a refined version of Skindex, a quality-of-life instrument for patients with<br /><br>skin diseases. Archives of dermatology, 1997. 133(11): p. 1433-1440. </p><br>
- Secondary Outcome Measures
Name Time Method